scholarly article | Q13442814 |
P356 | DOI | 10.1097/00001648-199307000-00003 |
P698 | PubMed publication ID | 8347738 |
P2093 | author name string | J Marks | |
D Jones | |||
A Glassman | |||
D Williamson | |||
R Anda | |||
E Eaker | |||
C Macera | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hopelessness | Q30317309 |
heart disease | Q190805 | ||
coronary artery disease | Q844935 | ||
P304 | page(s) | 285-294 | |
P577 | publication date | 1993-07-01 | |
P1433 | published in | Epidemiology | Q5382707 |
P1476 | title | Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults | |
P478 | volume | 4 |
Q74184411 | Abnormal brachial artery flow-mediated vasodilation in young adults with major depression |
Q26747514 | Acute Stress Decreases but Chronic Stress Increases Myocardial Sensitivity to Ischemic Injury in Rodents |
Q41582118 | Acute and chronic psychological risk factors for coronary syndromes: moderating effects of coronary artery disease severity |
Q35609437 | Addressing patients' emotional and spiritual needs |
Q99348028 | Adherence to Hypertension Medications and Lifestyle Recommendations among Underserved African American Middle-Aged and Older Adults |
Q51339832 | Age and angina as predictors of quality of life after myocardial infarction: a prospective comparative study. |
Q51108713 | Alexithymia and risk of death in middle-aged men. |
Q47345206 | Amyotrophic lateral sclerosis and hopelessness: psychosocial factors |
Q39203742 | An exploratory study of HIV+ adolescents' spirituality: will you pray with me? |
Q28377083 | An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial |
Q34480581 | Anger dysregulation, depressive symptoms, and health in married women and men. |
Q73143373 | Antidepressant use and the risk of myocardial infarction |
Q44801221 | Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk |
Q35580495 | Arterial endothelial function is impaired in treated depression |
Q37030311 | Assessing hopelessness in terminally ill cancer patients: development of the Hopelessness Assessment in Illness Questionnaire |
Q26746721 | Assessing perinatal depression as an indicator of risk for pregnancy-associated cardiovascular disease |
Q34201923 | Association between a serotonin transporter gene variant and hopelessness among men in the Heart and Soul Study |
Q90206835 | Association between depression and cardiovascular disease risk in general population of Korea: results from the Korea National Health and Nutrition Examination Survey, 2016 |
Q33829017 | Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study |
Q72064694 | Association of depression witk reduced heart rate variability in coronary artery disease |
Q47320684 | Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study |
Q36032535 | Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study |
Q34915763 | Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults |
Q51074217 | Attachment and loss experiences during childhood are associated with adult hostility, depression, and social support. |
Q64232017 | Baseline Body Mass Predicts Average Depressive Symptoms over the Next Two Decades for White but Not Black Older Adults |
Q44462740 | Behavioral and cardiovascular changes in the chronic mild stress model of depression |
Q35095473 | Biological mechanisms in the relationship between depression and heart disease |
Q35236309 | Broken heart: depression in cardiovascular disease |
Q39036157 | Can We Identify Minority Patients at Risk of Nonadherence to Antiplatelet Medication at the Time of Coronary Stent Placement? |
Q38247989 | Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers |
Q34356815 | Cardiac vagal control and theoretical models of co-occurring depression and anxiety: a cross-sectional psychophysiological study of community elderly |
Q37812473 | Cardiovascular Disease and Depression in Women |
Q37529769 | Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. |
Q49094399 | Cardiovascular disease and death associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). |
Q36804206 | Cardiovascular disease, psychosocial factors, and genetics: the case of depression |
Q74519103 | Cardiovascular events and mortality in newly and chronically depressed persons > 70 years of age |
Q36782460 | Central nervous system serotonin and clustering of hostility, psychosocial, metabolic, and cardiovascular endophenotypes in men. |
Q40439888 | Chronomic community screening reveals about 31% depression, elevated blood pressure and infradian vascular rhythm alteration |
Q26824899 | Clinical and biochemical manifestations of depression: relation to the neurobiology of stress |
Q43569254 | Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline |
Q37870585 | Clinical depression and inflammatory risk markers for coronary heart disease |
Q34248128 | Counseling via analogy: improving patient adherence in major depressive disorder |
Q50112677 | Counselling: filling a gap in general practice |
Q51012096 | Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. |
Q43914888 | Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression |
Q34703408 | Depressed mood and flow-mediated dilation: a systematic review and meta-analysis |
Q28210833 | Depression and cardiovascular comorbidity |
Q35189643 | Depression and cardiovascular disease: mechanisms of interaction |
Q37285362 | Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. |
Q73932678 | Depression and coronary heart disease: observations and questions |
Q34249257 | Depression and dysthymia |
Q34515234 | Depression and heart disease: evidence of a link, and its therapeutic implications |
Q35103458 | Depression and ischemic heart disease: overview of the evidence and treatment implications |
Q36581188 | Depression and the Risk of Myocardial Infarction and Coronary Death: A Meta-Analysis of Prospective Cohort Studies |
Q36712455 | Depression and the risk for cardiovascular diseases: systematic review and meta analysis |
Q77442959 | Depression and the risk of coronary heart disease in the Normative Aging Study |
Q28083271 | Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies |
Q34717232 | Depression as a predictor for coronary heart disease. a review and meta-analysis |
Q37143291 | Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms |
Q34959938 | Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms |
Q34786778 | Depression as a risk factor for non-suicide mortality in the elderly |
Q92889399 | Depression in Survivors of Acute Myocardial Infarction |
Q34394768 | Depression in chronic medical illness: the case of coronary heart disease |
Q77992173 | Depression in coronary heart disease. What is the appropriate diagnostic threshold? |
Q35236177 | Depression in late life: psychiatric-medical comorbidity |
Q33958344 | Depression in patients with cardiac disease: a practical review |
Q33875308 | Depression really does hurt your heart: stress, depression, and cardiovascular disease. |
Q40828024 | Depression risk in female patients with osteoporosis in primary care practices in Germany |
Q35189639 | Depression, mortality, and medical morbidity in patients with coronary heart disease |
Q33650132 | Depressive mood is independently related to stroke and cardiovascular events in a community |
Q35904974 | Depressive symptoms and cardiovascular reactivity to laboratory behavioral stress |
Q36854267 | Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause |
Q34677262 | Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications |
Q47349795 | Does psychological distress contribute to racial and socioeconomic disparities in mortality? |
Q39889855 | Education and Psychosocial Functioning Among Older Adults: 4-Year Change in Sense of Control and Hopelessness. |
Q74537327 | Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients |
Q44615995 | Effect of negative emotions on frequency of coronary heart disease (The Normative Aging Study) |
Q37211368 | Effect of positive well-being on incidence of symptomatic coronary artery disease |
Q36998904 | Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial |
Q35122429 | Effects of a 2-year behavioral weight loss intervention on sleep and mood in obese individuals treated in primary care practice |
Q35150787 | Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study |
Q50904847 | Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type D characteristics. |
Q36924981 | Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia |
Q45139118 | Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram |
Q73411166 | Elevated P-selectin on platelets in depression: response to bupropion |
Q36815326 | Enculturation, perceived stress, and physical activity: implications for metabolic risk among the Yup'ik--the Center for Alaska Native Health Research Study |
Q35189634 | Epidemiology of comorbid coronary artery disease and depression |
Q35553004 | Epidemiology, diagnosis, and management of depression in patients with CKD. |
Q73143335 | Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents |
Q30904046 | Exploratory multivariate analysis of the effect of fatty fish consumption and medicinal use on heart rate and heart rate variability data |
Q37146009 | Exploring the complexity of cardiometabolic risk in women |
Q35804604 | Feelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study |
Q36134021 | Frequency of depression among patients with acute coronary syndrome, eastern region, saudi arabia |
Q33958371 | Gender and psychosomatic aspects of ischemic heart disease. |
Q37206983 | Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. |
Q33869891 | Genetic vulnerability and phenotypic expression of depression and risk for ischemic heart disease in the Vietnam era twin study of aging |
Q33958296 | Going to the heart of the matter: do negative emotions cause coronary heart disease? |
Q39001158 | Health decline in eastern Europe |
Q35520767 | Heart and mind: (1) relationship between cardiovascular and psychiatric conditions |
Q51924759 | Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores. |
Q73423743 | Heart rate variability before and after treatment with electroconvulsive therapy |
Q37400361 | Heart rate variability in depressed elderly |
Q38021672 | Heartache and heartbreak--the link between depression and cardiovascular disease |
Q28210257 | Homeopathy--what are the active ingredients? An exploratory study using the UK Medical Research Council's framework for the evaluation of complex interventions |
Q35308340 | Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults |
Q41519173 | How Safe Are Serotonin Reuptake Inhibitors for Depression in Patients with Coronary Heart Disease? |
Q38526162 | Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis. |
Q33601902 | Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy |
Q90725224 | Implications of Systemic Inflammation and Periodontitis for Major Depression |
Q33773597 | Individual income, income inequality, health, and mortality: what are the relationships? |
Q57392445 | Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia∗∗The opinions and assertions expressed herein are those of the authors and are not to be construed as reflect |
Q38131387 | Inflammation, heart disease, and depression |
Q34958515 | Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases |
Q36622524 | Investigation of Anxiety and Depression in Patients with Chronic Diseases |
Q36351021 | Is there a role for immune-to-brain communication in schizophrenia? |
Q33474606 | Leisure-time physical activity, cardiorespiratory fitness and feelings of hopelessness in men |
Q33813546 | Lifetime manic spectrum episodes and all-cause mortality: 26-year follow-up of the NIMH Epidemiologic Catchment Area Study |
Q33181920 | Lipids and psychosocial status in aboriginal persons with and at risk for Type 2 diabetes: implications for tertiary prevention |
Q52222206 | Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. |
Q33921959 | Management of comorbid depression and heart disease: the time has (almost) come |
Q28391323 | Mastery, perceived stress and health-related behaviour in northeast Arnhem Land: a cross-sectional study |
Q45023097 | Measuring hopelessness and life orientation in Pakistani adolescents |
Q33214937 | Mediation and modification of the association between hopelessness, hostility, and progression of carotid atherosclerosis |
Q34786784 | Medical comorbidity and late life depression: what is known and what are the unmet needs? |
Q35561539 | Mental health issues associated with cardiovascular disease in women |
Q43620328 | Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992. |
Q51943038 | One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. |
Q34580335 | Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states |
Q34655157 | Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma |
Q44314276 | Pathways linking depression, adiposity, and inflammatory markers in healthy young adults |
Q37409451 | Persistent versus transient depressive symptoms in relation to platelet hyperactivation: a longitudinal analysis of dementia caregivers |
Q24653735 | Placebo effects: clinical aspects and neurobiology |
Q40641442 | Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment |
Q60655792 | Platelet surface glycoprotein expression in post-stroke depression: a preliminary study |
Q77462388 | Predicting response to cognitive behavior therapy of depression in type 2 diabetes |
Q28710054 | Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial |
Q77714696 | Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention |
Q34742647 | Primary care patients with depression are less accepting of treatment than those seen by mental health specialists |
Q48957291 | Psychiatric Aspects of Heart and Lung Disease in Critical Care |
Q57111824 | Psychological distress, physical illness and mortality risk |
Q43578861 | Psychological distress, physical illness and risk of myocardial infarction in the Caerphilly study |
Q35418234 | Psychological distress, physical illness, and risk of coronary heart disease |
Q33958326 | Psychological factors affecting a medical condition: ischemic coronary heart disease |
Q35401050 | Psychosocial aetiology of chronic disease: a pragmatic approach to the assessment of lifetime affective morbidity in an EPIC component study |
Q36650717 | Psychosocial outcomes of an exercise maintenance intervention after phase II cardiac rehabilitation |
Q40866465 | Psychosocial risk factors for coronary heart disease in women |
Q58707532 | Putative Inflammatory Sensitive Mechanisms Underlying Risk or Resilience to Social Stress |
Q37308019 | Racial Disparities in Pain Management in Primary Care |
Q77323964 | Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study |
Q48848007 | Relationships between vascular dysfunction, circulating endothelial progenitor cells, and psychological status in healthy subjects |
Q34865829 | Resilience to the effects of social stress: evidence from clinical and preclinical studies on the role of coping strategies |
Q90672013 | Retinal correlates of psychiatric disorders |
Q35558259 | Role of peripheral vascular resistance for the association between major depression and cardiovascular disease |
Q82093200 | Role of psycho-social factors in CVD |
Q40668150 | Self-reported depression in psoriasis is associated with subclinical vascular diseases. |
Q33971187 | Sexual activity and cardiac risk: is depression a contributing factor? |
Q63353237 | Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort |
Q35772824 | Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease? |
Q33967769 | Sociodemographic factors and depressive symptoms in hospitalized patients with heart failure. |
Q37035595 | Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models |
Q43967557 | Stronger symptoms of depression predict high coronary heart disease mortality in older men and women |
Q41856851 | Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. |
Q35410024 | Temperament in young adulthood and later mortality: prospective observational study |
Q34980524 | The St. Louis African American health-heart study: methodology for the study of cardiovascular disease and depression in young-old African Americans |
Q24631680 | The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology |
Q39748236 | The hidden health burden of environmental degradation: disease comorbidities and dryland salinity. |
Q37335304 | The potential of a placebo/nocebo effect in pharmacogenetics |
Q36927588 | The role of perinatal problems in risk of co-morbid psychiatric and medical disorders in adulthood |
Q34105879 | Type D personality. A potential risk factor refined |
Q28345555 | Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction |
Q33632295 | Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study |
Q31110410 | Validity of vascular depression as a specific diagnostic: a review |
Q37211636 | When mental health becomes health: age and the shifting meaning of self-evaluations of general health |
Q36143551 | Why does Income Relate to Depressive Symptoms? Testing the Income Rank Hypothesis Longitudinally |
Q35800981 | Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure |
Q78627470 | [A walk through the epistemology of stress] |
Q79932716 | [Depression, stress and coronary diseases in the aged] |
Q56769291 | [Nocebo effects and negative suggestion in anesthesia] |
Q74042696 | [The detection of mental disorders by physicians who are not psychiatrists: usefulness of the PRIME-MD questionnaire] |
Search more.